Polycystic Ovary Syndrome

Detailed Overview

PCOS is far more than a reproductive disorder; it is a profound metabolic condition. The core pathophysiologic driver in most patients is peripheral insulin resistance, leading to compensatory hyperinsulinemia. High insulin levels directly stimulate the ovarian theca cells to overproduce androgens and simultaneously decrease hepatic production of Sex Hormone-Binding Globulin (SHBG), further increasing free, active testosterone. This androgen excess disrupts follicular maturation, leading to multiple arrested cysts (polycystic ovaries) and failure to ovulate. Long-term, PCOS carries significant risks for type 2 diabetes, metabolic syndrome, cardiovascular disease, and endometrial hyperplasia/cancer.

Epidemiology & Demographics

The most common endocrine disorder in reproductive-aged women, affecting 6-12% of women worldwide. Prevalence is increasing parallel to global obesity rates.

Etiological Mechanism

Multifactorial. Involves complex genetic susceptibility interacting with environmental factors, primarily diet and lifestyle leading to obesity, which exacerbates underlying insulin resistance and androgen excess.

Primary Causes

Hypothalamic-pituitary axis dysregulation (increased GnRH pulse frequency causing high LH to FSH ratio), primary ovarian hyperandrogenism, and severe peripheral insulin resistance are the primary drivers.

• Genetics: High heritability; risk is 30-50% if a first-degree female relative has PCOS.
• Obesity: Adipose tissue exacerbates insulin resistance and aromatizes androgens to estrogens.
• Intrauterine Environment: Prenatal exposure to excess androgens may program the fetal hypothalamus/ovaries.

Three main defects interact: 1) Insulin resistance: hyperinsulinemia stimulates theca cell androgen production and inhibits hepatic SHBG. 2) Ovarian dysfunction: excess androgens prematurely luteinize granulosa cells, arresting follicle growth (creating the 'cysts') and preventing ovulation. 3) Neuroendocrine defect: abnormally rapid GnRH pulses favor LH production over FSH. The high LH stimulates theca cells to produce more testosterone, while low FSH impairs the granulosa cells' ability to convert that testosterone to estradiol via aromatase. This creates a vicious cycle of hyperandrogenism and anovulation. The chronic unopposed estrogen (from peripheral conversion of androgens) without progesterone (due to anovulation) drives endometrial proliferation.

Characteristic Clinical Presentation

• Menstrual Irregularity: Oligomenorrhea (<9 cycles/year) or amenorrhea (no cycle for ≥3 months).
• Hirsutism: Excess terminal body hair in a male pattern (face, chest, lower abdomen, back).
• Acne and Alopecia: Severe cystic acne resisting standard treatment; male-pattern hair thinning.
• Infertility: Difficulty conceiving due to anovulation.
• Weight Gain: Difficulty losing weight, central/visceral obesity.

Physical Examination Signs

• Acanthosis Nigricans (velvety hyperpigmented skin on the neck/axillae, indicating severe insulin resistance)
• Skin tags (acrochordons)
• Increased BMI and waist circumference

• Type 2 Diabetes Mellitus: More than 50% of women with PCOS develop prediabetes or diabetes before age 40.
• Endometrial Cancer: 3-fold increased risk due to chronic unopposed estrogen stimulation.
• Obstructive Sleep Apnea: Highly prevalent independently of BMI.
• Nonalcoholic Fatty Liver Disease (NAFLD): Common metabolic complication.

Diagnostic Criteria & Guidelines

Rotterdam Criteria (requires 2 out of 3, after exclusion of other etiologies): 1) Oligo- and/or anovulation. 2) Clinical and/or biochemical signs of hyperandrogenism. 3) Polycystic ovaries on ultrasound (≥20 follicles per ovary or ovarian volume ≥10 mL).

Differential Diagnosis

• Nonclassic Congenital Adrenal Hyperplasia (check 17-OH progesterone)
• Hypothyroidism (check TSH)
• Hyperprolactinemia (check Prolactin)
• Cushing's Syndrome (check cortisol)
• Androgen-secreting ovarian or adrenal tumor (if testosterone >150 ng/dL and rapid virilization)

Laboratory Tests & Biomarkers

• Total and Free Testosterone: Elevated (total often 50-100 ng/dL, free testosterone is a more sensitive marker).
• LH/FSH Ratio: Often elevated (>2:1 or 3:1), though not formally required for diagnosis.
• Sex Hormone-Binding Globulin (SHBG): Decreased.
• 2-Hour Oral Glucose Tolerance Test (OGTT): Impaired fasting glucose or frank diabetes; lipid panel shows low HDL and high triglycerides.

Imaging Modalities & Findings

• Transvaginal Pelvic Ultrasound:

• Adolescent PCOS
  Difficult to diagnose due to normal puberty mimicking symptoms; focused on establishing cycle regularity.
• Reproductive PCOS
  Primary concerns are fertility, hirsutism, and preventing endometrial hyperplasia.
• Menopausal PCOS
  Reproductive symptoms wane, but extreme risk for cardiovascular disease, Type 2 DM, and dyslipidemia persists.

Second-Line & Adjunctive Therapy

For refractory hirsutism: Antiandrogens such as Spironolactone 100-200 mg/day (MUST be prescribed with strict contraception due to risk of feminizing male fetuses). For infertility: Clomiphene citrate or injectable gonadotropins. For severe obesity: GLP-1 receptor agonists (e.g., Semaglutide) or bariatric surgery.

Surgical & Procedural Management

Laparoscopic ovarian drilling (diathermy) is a second-line treatment for women with clomiphene/letrozole-resistant PCOS to induce ovulation by destroying androgen-producing stroma.

Recommended Lifestyle Changes

Patient Counseling & Advice

Explain that PCOS is a lifelong condition requiring chronic management. Emphasize that while it is a major cause of infertility, ovulation can be successfully induced in most women when they are ready to conceive. Stress the critical importance of having at least 4 periods a year (induced via progestin withdrawal if necessary) to prevent uterine cancer. Discuss the high risk of diabetes and the need for rigorous lifestyle management.

Follow-Up & Monitoring Schedule

Annual screening for BP, BMI, and depression. A 2-hour OGTT and fasting lipid profile every 1-3 years. Monitor liver enzymes if on Metformin or suspected of having NAFLD.

Preventive Strategies

Cannot be prevented, but early lifestyle interventions (diet, exercise) in adolescents with a family history can significantly mitigate the development of severe phenotypes and metabolic complications.

Good for symptom control and fertility with appropriate medical management. Long-term prognosis depends heavily on the prevention and management of metabolic and cardiovascular comorbidities.